Predictive Oncology Inc. (NASDAQ:POAI) Sees Large Growth in Short Interest

Predictive Oncology Inc. (NASDAQ:POAI) was the recipient of a significant growth in short interest in January. As of January 31st, there was short interest totalling 626,700 shares, a growth of 36.9% from the January 15th total of 457,800 shares. Currently, 9.6% of the company’s shares are sold short. Based on an average trading volume of 1,910,000 shares, the short-interest ratio is currently 0.3 days.

Predictive Oncology Stock Performance

Shares of Predictive Oncology stock traded up $0.14 on Friday, hitting $1.62. 308,911 shares of the company traded hands, compared to its average volume of 2,838,906. The stock’s 50 day moving average price is $1.18 and its 200-day moving average price is $0.94. Predictive Oncology has a 52 week low of $0.55 and a 52 week high of $3.76.

Analyst Ratings Changes

Separately, HC Wainwright reaffirmed a “neutral” rating on shares of Predictive Oncology in a research note on Friday, November 15th.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.